Cancer Types - CancerCareE | Advanced Cancer Treatments in China

info@cancercaree.com +86 186 1174 1613 (China)

Comprehensive Guide to Cancer Types

Explore detailed information on various cancer types, advanced treatment options, and clinical trials available in China and globally.

Get Treatment Evaluation How to Spot Early Signs of Cancer

Blood Cancer

Leukemia, Lymphoma, Myeloma

85%

Response Rate

70%

Cure Chance

CAR-T Therapy Immunotherapy Stem Cell Transplant

Clinical Trials in China

CAR-T Therapy for Recurrent B-Cell Lymphoma

Shanghai Cancer Center

Blood cancers have seen remarkable progress with new treatments like CAR-T therapy.

Breast Cancer

Invasive Ductal Carcinoma

91%

5-Year Survival Rate

75%

Early Detection

Targeted Therapy Immunotherapy Breast-Conserving Surgery

Clinical Trials

Targeted Therapy Study for HER2+

Beijing Cancer Hospital

Advanced treatments include targeted therapies and breast-conserving surgeries.

Lung Cancer

Non-Small Cell, Small Cell

65%

Early-Stage Survival Rate

80%

Immunotherapy Response

Immunotherapy Targeted Therapy Minimally Invasive Surgery

Advanced treatments for lung cancer with immunotherapy and targeted molecular therapies.

Prostate Cancer

Adenocarcinoma

98%

5-Year Survival Rate

90%

Localized Cure Rate

Radiation Therapy Hormone Therapy Robotic Surgery

Precise treatments including robotic surgery and advanced radiation techniques.

Colon Cancer

Colorectal Cancer

90%

Early-Stage Survival Rate

65%

Advanced Stage

Minimally Invasive Surgery Targeted Therapy Immunotherapy

Advanced surgical techniques combined with targeted therapies for better outcomes.

Brain Cancer

Glioblastoma, Glioma

40%

5-Year Survival Rate

75%

Tumor Control

Neurosurgery Radiation Targeted Therapy

Clinical Trials

New Treatment for Glioma

Shanghai Neurology Center

Advanced neurosurgical techniques and targeted therapies for brain tumors.

Skin Cancer

Melanoma, Basal Cell Carcinoma

99%

Early Detection Cure

85%

Advanced Stage Survival

Mohs Surgery Immunotherapy Targeted Therapy

Advanced surgical techniques and innovative immunotherapies for skin cancer.

Pancreatic Cancer

Adenocarcinoma

10%

5-Year Survival Rate

80%

Surgical Success

Whipple Procedure Targeted Therapy Immunotherapy

Clinical Trials

New Treatment for Pancreatic Cancer

Beijing Medical Center

Advanced surgical procedures and emerging targeted therapies.

Ovarian Cancer

Epithelial Ovarian Cancer

92%

Early-Stage Survival Rate

75%

Treatment Response

Debulking Surgery Targeted Therapy Chemotherapy

Advanced debulking surgeries and targeted therapies for ovarian cancer.

Liver Cancer

Hepatocellular Carcinoma

70%

Early-Stage Survival Rate

60%

Transplant Success

Liver Resection Targeted Therapy Immunotherapy

Clinical Trials

Immunotherapy for Liver Cancer

Shanghai Liver Center

Advanced liver resection techniques and new immunotherapies.

Gastric Cancer

Stomach Cancer

68%

Early-Stage Survival Rate

75%

Surgical Success

Gastrectomy Targeted Therapy Immunotherapy

Advanced surgical techniques and targeted therapies for gastric cancer.

Thyroid Cancer

Papillary, Follicular

98%

5-Year Survival Rate

95%

Treatment Success

Thyroidectomy Radioactive Iodine Targeted Therapy

Minimally invasive surgeries and targeted therapies for thyroid cancer.

Esophageal Cancer

Squamous Cell, Adenocarcinoma

47%

5-Year Survival Rate

80%

Early-Stage Success

Esophagectomy Radiation Targeted Therapy

Advanced surgical procedures and combined therapies.

Cervical Cancer

Squamous Cell Carcinoma

92%

Early-Stage Survival Rate

80%

Treatment Success

Hysterectomy Radiation Targeted Therapy

Minimally invasive surgeries and advanced radiation techniques.

Bladder Cancer

Transitional Cell Carcinoma

77%

5-Year Survival Rate

85%

Early-Stage Success

TURBT Immunotherapy BCG Therapy

Advanced surgical techniques and immunotherapy for bladder cancer.

Kidney Cancer

Renal Cell Carcinoma

75%

5-Year Survival Rate

90%

Localized Success

Nephrectomy Targeted Therapy Immunotherapy

Kidney-preserving surgeries and advanced targeted therapies.